Biomarkers of cartilage turnover. Part 2: Non-collagenous markers

Vet J. 2010 Jul;185(1):43-9. doi: 10.1016/j.tvjl.2010.04.012. Epub 2010 May 21.


Osteoarthritis (OA) results in the destruction and breakdown of articular cartilage matrix. Breakdown of the cartilage proteoglycan component results in the generation of constituent fragments that can be detected in the blood, synovial fluid or urine. Non-collagenous, non-proteoglycan components of cartilage can also be detected following their release as a result of turnover and disease. OA also alters the circulating profile of metabolites in the body. Metabolomic strategies have been used to distinguish populations with OA from normal populations by the creation of a metabolomic 'fingerprint' attributable to the disease. This paper is the second part of a two-part review and describes some of the techniques used to measure the concentrations of some of these 'non-collagenous' biomarkers, and how the application of these measurements assists the study of joint disease. Collagen-based biomarkers were discussed in part one.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers / analysis
  • Biomarkers / metabolism*
  • Cartilage, Articular / metabolism
  • Collagen Type II / metabolism
  • Dog Diseases / diagnosis
  • Dog Diseases / metabolism*
  • Dogs
  • Extracellular Matrix Proteins / analysis
  • Extracellular Matrix Proteins / metabolism*
  • Glycoproteins / analysis
  • Glycoproteins / metabolism*
  • Matrilin Proteins
  • Osteoarthritis / metabolism
  • Osteoarthritis / veterinary*
  • Proteoglycans / analysis
  • Proteoglycans / metabolism*


  • Biomarkers
  • Collagen Type II
  • Extracellular Matrix Proteins
  • Glycoproteins
  • Matrilin Proteins
  • Proteoglycans